Answers are grounded in this paper and cite their sources.
Background. A meta-analysis of 14 randomised controlled trials (663 participants) reports that camel milk consumption reduces HbA1c by 1.24 percentage points and daily insulin dose by 16.72 U in patients with diabetes. These are large effects for a food. This reanalysis asks whether the trial corpus is capable of supporting them. Methods. Trial-level design characteristics and pooled outcome statistics were extracted from the published meta-analysis (AlKurd et al., Nutrients 2022, CC BY). No primary trial reports were consulted. Blinding completeness, outcome-wise heterogeneity, effect plausibility against indicative values for established glucose-lowering agents, and the sample sizes required to adjudicate the corpus's internal discrepancy were computed. Results. All 14 trials (100%) used "usual care" as comparator, a contrast that cannot be blinded. Adequate sequence generation was reported in 3/14, allocation concealment in 1/14, participant blinding in 2/14, and blinded outcome assessment in 2/14; one trial (7.1%) satisfied all four. Of eight pooled outcomes, six were non-significant, including every mechanistic marker (fasting serum insulin, HOMA-IR, C-peptide, insulin antibodies). The two significant outcomes, HbA1c and insulin dose, are precisely the two that depend on an unblinded investigator, insulin dose being titrated by that investigator. Median I-squared was 94%, with none below 89%. In subgroup analysis, fresh (raw) milk yielded -1.50 points HbA1c (I-squared = 85%) against -0.31 for heat-treated or fermented milk (I-squared = 0.0%): a 4.8-fold difference in which the only internally consistent subgroup in the entire corpus is also the one reporting the smallest effect. Conclusions. The corpus is not weak evidence of an effect; its principal result is not separable from the measurement bias that produced it, and additional participants would not repair this. The parsimonious hypothesis is that the true HbA1c effect is near -0.3 points. The discriminating experiment is a blinded raw-versus-pasteurised comparison, requiring 28 participants if the published subgroup difference is real and 250 under non-inferiority framing. It has not been conducted in 22 years, despite being the least expensive trial in the field and despite an independently documented association between daily raw camel-milk consumption and Brucella seropositivity.
No takes yet. Share an insight, caveat, or question.
KARIM ADAMINI EL GHOUILI (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: